Jazz Pharmaceuticals
JAZZ
JAZZ
382 hedge funds and large institutions have $5.75B invested in Jazz Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 136 increasing their positions, 147 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less funds holding
Funds holding: 407 → 382 (-25)
32% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 69
53% less call options, than puts
Call options by funds: $22.4M | Put options by funds: $47.8M
Holders
382
Holding in Top 10
4
Calls
$22.4M
Puts
$47.8M
Top Buyers
| 1 | +$142M | |
| 2 | +$53.2M | |
| 3 | +$51.7M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$40.1M |
| 5 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$36.3M |
Top Sellers
| 1 | -$60.1M | |
| 2 | -$45.7M | |
| 3 | -$33.3M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$26M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$24.2M |